OBITUARY Fritz Bühler

Fritz_Buehler.pngCroix_noire_1.jpg

Obituary_Fritz_Bühler.pdf

E-learning Modules
Ethik
E-Library
A European Approach to Clinical Investigator (CLIC)Clinical investigator 
Strategic position paper about proposing clinical investigator training in Europe.

Medicines Regulatory Affairs
Four universities (Copenhagen, Basel, Hertfordshire and King’s College, London) now collaborate to introduce a European Masters Programme in Medicines Regulatory Affairs.

Trainees Membership

PharmaTrain has established Global Shared Standards for Education and Training in Medicines Development and assessed courses and course providers. Visit courses that are recognised by PharmaTrain to benefit from best quality.

Driving your professional career
As a professional interested in education and training in the field of discovery, development, regulation and lifecycle management of medicines, you can boost your competence and enhance performance, broaden your horizons and network – to drive your career.

New high-quality training standards
PharmaTrain has implemented reliable standards for highquality postgraduate education and training in Medicines Development – in Europe and now globally. Training Centres, which offer Diploma Courses, Master Programmes and CPD Modules/Short Courses under the PharmaTrain brand share the high standards and undergo quality assessments.

Up-to-date learning content and learning outcomes
In partnership with industry and academia, PharmaTrain has defined 180 topics along the road from molecule to patient: the comprehensive Syllabus of Medicines Development. These items are mapped to 60 Learning Outcomes. You can be sure that all PharmaTrain branded courses will cover these.

PharmaTrain recognised Training Centres
PharmaTrain awards training centres the “PharmaTrain Centre Recognition” or “PharmaTrain Centre of Excellence”. More than 12 training centres have already been assessed (see the list on www.pharmatrain.eu).

Developed by university-industry partnership
The PharmaTrain project, a public-private partnership, was funded by the Innovative Medicines Initiative IMI (see www.imi.europe.eu). The PharmaTrain Federation aims to build on this initiative and further developing its global network.

Your benefits in joining PharmaTrain Federation
Benefit from the unique network of members from university and non-university course providers, companies, professional and regulatory organisations. as well as individuals actively involved in medicines development and former trainees.

More about how to join the PharmaTrain Federation.